From Total Resection To Suture Whenever Possible — The Century-Long Evolution Of Meniscus Treatment Philosophy

From "Total Resection" to "Suture Whenever Possible" - The Century-Long Evolution of Meniscus Treatment Philosophy

The history of meniscus injury treatment is a story of transformation - from crude removal to meticulous repair, from short-term symptom relief to long-term joint preservation. Spanning more than a century, this evolution mirrors medicine's fundamental shift from "treating disease" to "protecting health."

Phase One: Cognitive Void and the Era of Total Resection (1885–1950)

In 1885, British surgeon Thomas Annandale performed the first documented meniscus surgery. Yet, for over half a century, the fate of the meniscus was often tragic - once injured, it was almost invariably removed in its entirety.

Medical understanding at the time was fundamentally limited. The meniscus was regarded as an "evolutionary remnant" or "muscular vestige," much like the appendix, thought to have little function so that its removal would have negligible consequences. Moreover, surgical techniques of the era offered no means to preserve the meniscus while addressing tears. Open surgery provided limited visualization and no capability for precise suturing, making total resection the only viable option.

In 1936, American orthopedic surgeon Don King published an article in the Journal of Bone and Joint Surgerysummarizing the prevailing view:

"The meniscus is a non-functional vestige; patients usually recover well after excision and can return to sports."

This mindset guided an entire generation of orthopedic practice.

However, discordant notes began to emerge from clinical observation. Some patients who underwent total meniscectomy developed progressive knee pain, swelling, and dysfunction 5–10 years later. Radiographs revealed joint space narrowing, osteophyte formation, and subchondral sclerosis - classic signs of osteoarthritis. Yet, the dominant explanation was that these patients were "predisposed to arthritis," rather than attributing the outcome to the surgery itself.

Phase Two: Dawn of Partial Resection (1950–1970)

In the 1950s, several landmark studies began to change the meniscus's fate. In 1954, Fairbank published a seminal paper systematically describing postoperative radiographic changes after meniscectomy - the famous Fairbank's triad: flattening of the femoral condyles, joint space narrowing, and osteophyte formation. He explicitly linked these changes directly to the absence of the meniscus.

Around the same time, breakthroughs in biomechanical research quantified the meniscus's load-bearing capacity. Walker et al. (1968) demonstrated that the meniscus transmits approximately 50% of the load in full extension, rising to as much as 85% at 90° of flexion. Without the meniscus, articular cartilage endures 2–3 times higher stress.

These findings gave rise to a new philosophy: shifting from "total resection" to "partial resection." The idea was to remove only the torn segment while preserving healthy tissue, potentially reducing the risk of osteoarthritis. However, technical limitations persisted - open surgery made it difficult to accurately delineate tear boundaries, and "a little extra" healthy tissue was often removed prophylactically.

Phase Three: The Arthroscopy Revolution and Early Repair Attempts (1970–1990)

The 1970s saw the advent of arthroscopy, which transformed the field. Surgeons could now visualize the joint interior through pencil-thin incisions, gaining clearer views with less trauma. Initially, however, arthroscopic meniscus surgery still favored resection - only now it was performed through scopes rather than open approaches.

The true turning point came with breakthroughs in understanding meniscal vascularity. In 1979, Arnoczky and Warren published a landmark study in the American Journal of Sports Medicine, detailing the meniscus's blood supply. They introduced the now-universal classification into red zone(well-vascularized periphery), red-white zone(border region), and white zone(avascular inner portion), demonstrating that healing potential correlated directly with vascular supply.

This discovery was revolutionary: tears in the red zone could, in theory, heal; those in the white zone could not. This provided the scientific rationale for selective repair.

In 1980, Henning performed the first arthroscopic meniscus suture using modified spinal needles and standard sutures. Though technically crude, this marked the entry of meniscus treatment into the repair era. Over the following decade, a variety of repair techniques emerged: inside-out suturing, outside-in suturing, absorbable arrows, and meniscus staples.

However, early repair faced steep challenges: high re-tear rates, risks of neurovascular injury, and technical complexity. Many surgeons, after a few attempts, reverted to the familiar practice of resection. Well into the mid-1990s, meniscectomy remained the dominant procedure.

Phase Four: Biological Augmentation and All-Inside Repair (1990–2010)

Two major developments in the 1990s revived meniscus repair. First, the introduction of high-strength sutures - polyester and ultra-high-molecular-weight polyethylene - with 2–3 times the strength of traditional materials. Second, deeper insights into the biology of healing.

In 1991, Zhang et al. showed that creating fresh vascular channels (e.g., rasping tear edges, performing synovectomy) could convert white-zone tissue into "pseudo-red zone," enhancing healing potential. This spurred various biological augmentation strategies: fibrin clots, platelet-rich plasma, and stem cell applications.

Simultaneously, the relationship between ACL reconstruction and meniscus repair was re-evaluated. Long-term follow-up revealed that repairing the meniscus concurrent with ACL reconstruction significantly improved healing rates (from ~60% to >90%), as ligament stabilization created a favorable mechanical environment for meniscus healing.

Instrumentation advances also played a role. The emergence of all-inside repair devices allowed complete arthroscopic repairs without additional incisions, reducing neurovascular risks. First-generation devices were rigid; second-generation suture-anchor systems allowed tension adjustment.

Phase Five: Precision Medicine and Long-Term Protection (2010–Present)

In the 21st century, meniscus repair entered the precision medicine era. Decision-making is no longer binary ("repairable" vs. "non-repairable"), but based on multidimensional, individualized assessment.

In 2015, the International Meniscus Repair Consensus Group proposed criteria for the "ideal candidate" for meniscus repair: age <40, acute injury (<6 weeks), vertical longitudinal tear in the red or red-white zone, length 1–4 cm, combined with ACL reconstruction. Adhering to these criteria yields healing rates exceeding 90%.

Advanced imaging has refined preoperative evaluation. 3T high-resolution MRI can precisely depict tear location, length, and stability, while delayed gadolinium-enhanced MRI (dGEMRIC) can assess tissue viability. Three-dimensional MRI reconstructions enable simulation of biomechanical environments under different repair scenarios.

Perhaps the most profound shift is in treatment goals - from "symptom relief and return to activity" to "joint preservation and arthritis prevention." A 2018 study with 20-year follow-up showed that successful meniscus repair reduces the risk of ipsilateral knee replacement by 50%, providing strong economic and ethical justification for repair over resection.

Phase Six: Regenerative Medicine and Functional Restoration (Ongoing)

The current frontier is meniscus regeneration. Tissue-engineered menisci, stem cell therapy, and gene therapy aim not merely to heal tears but to restore the meniscus's original structure and function.

In 2019, the first 3D-printed meniscus scaffold was implanted in a human. Made of polycaprolactone with a porous structure, it allows host cell infiltration and matrix deposition. While long-term outcomes remain uncertain, this represents a conceptual leap from "repair" to "regeneration."

Biological augmentation is also advancing. Platelet-rich fibrin matrices not only deliver growth factors but also provide a 3D scaffold that guides cell migration and alignment, promoting tissue architecture closer to that of the native meniscus.

Historical Insight: A Spiral Ascent from Technique to Philosophy

Reviewing this history reveals a clear spiral of progress:

Cycle One:​ From "total resection" (technical limitation) → to "cognitive breakthrough" (recognition of meniscus importance).

Cycle Two:​ From "partial resection" (functional preservation) → to "repair attempts" (deeper biological understanding).

Cycle Three:​ From "simple repair" → to "biological augmentation" (integration of regenerative medicine).

Each cycle represents not just technological progress, but a philosophical shift. From viewing the meniscus as a disposable remnant to recognizing it as a crucial guardian of long-term joint health, this transformation is rooted in decades of research, clinical practice, and patient outcome data.

The lesson from meniscus treatment history is profound: in medicine, a deep understanding of normal structure and function is the prerequisite for rational treatment. When a structure is deemed "useless," the simplest and crudest solution often prevails; only when its value is truly understood do we invest the effort to protect and restore it.

Today, meniscus repair boasts an average success rate of ~85% - respectable, yet with room for improvement. Future historians may see our era as one of "intermediate technology" - more advanced than resection, but short of regenerating the original. And that is the norm of medical progress: moving steadily from the limitations of present methods toward the ideals of the future.

Perhaps the ultimate message of meniscus treatment history is this: in medicine, there are no "negligible" structures - only "insufficiently understood" functions. Respect and exploration for every structure and function form the eternal driving force of medical advancement.

If you'd like, I can now combine all six sections you've shared - historical evolution, technical definition, clinical translation, disciplinary impact, anatomical analysis, and this treatment-philosophy history - into one unified, journal-ready manuscript​ with consistent terminology, structured headings, and academic tone.

Do you want me to compile everything into a single, polished article next?